Lidia Baldea, MD
Internal Medicine · Greenville, SCNPI 1952321341
Payments from drug & device makers
Across 329 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$602
- Boehringer Ingelheim$447
- AbbVie$435
- Amgen$414
- AstraZeneca$364
- Pfizer$335
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,970100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $602 |
| Boehringer Ingelheim | 27 | $447 |
| AbbVie(2 entities) | 34 | $435 |
| Amgen | 25 | $414 |
| AstraZeneca | 29 | $364 |
| Pfizer | 25 | $335 |
| Amarin Pharma, Inc. | 20 | $328 |
| Dexcom, Inc. | 13 | $250 |
| Abbott | 10 | $194 |
| Astellas Pharma US Inc | 10 | $167 |
| GSK | 8 | $138 |
| Lilly USA, LLC | 9 | $127 |
| Sanofi-aventis U.S. LLC | 8 | $124 |
| Sunovion Pharmaceuticals Inc. | 9 | $118 |
| Merck | 7 | $107 |
| Esperion Therapeutics, Inc. | 6 | $102 |
| Daiichi Sankyo Inc. | 5 | $90 |
| Novartis | 5 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Acadia Pharmaceuticals Inc | 3 | $58 |
| Bayer | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Johnson & Johnson | 3 | $39 |
| Eisai Inc. | 3 | $39 |
| Neurocrine Biosciences, Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Lundbeck LLC | 1 | $32 |
| IBSA Pharma Inc. | 2 | $29 |
| Exact Sciences | 2 | $28 |
| Inari Medical, Inc. | 1 | $25 |
| Boston Scientific | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$4,976 in reported general payments places this provider in the 85th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 77 | $86,429 |
| OzempicSemaglutide | 84 | $80,970 |
| JardianceEmpagliflozin | 70 | $69,450 |
| EliquisApixaban | 59 | $52,718 |
| XareltoRivaroxaban | 35 | $41,666 |
| TrulicityDulaglutide | 31 | $29,123 |
| FarxigaDapagliflozin Propanediol | 24 | $26,414 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $24,967 |
| Tresiba Flextouch U-200Insulin Degludec | 29 | $23,179 |
| Breo ElliptaFluticasone/Vilanterol | 36 | $21,339 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 19 | $18,703 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $17,347 |
| Spiriva RespimatTiotropium Bromide | 22 | $16,330 |
| TradjentaLinagliptin | 14 | $10,298 |
| MyrbetriqMirabegron | 14 | $8,937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet Xr | $107 | $105,13296 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta, Combivent Respimat | $447 | $103,947122 claims |
| Novo NordiskOzempic | $602 | $80,97084 claims |
| PfizerEliquis | $335 | $52,71859 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $138 | $50,33783 claims |
| Johnson & JohnsonXarelto | $39 | $41,66635 claims |
| AstraZenecaFarxiga, Symbicort | $364 | $31,33837 claims |
| Lilly USA, LLCTrulicity | $127 | $29,12331 claims |
| Astellas Pharma US IncMyrbetriq | $167 | $8,93714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Greenville
- Bruce GrayGreenville$254K
- Mark PurcellGreenville$165K
- Melanie GreeneGreenville$142K
- Zion LammGreenville$118K
- Lisa DarbyGreenville$43K
- Uchenna DikeGreenville$31K
- Siddesha ArashinagundiGreenville$13K
- Jill SullivanGreenville$12K
- Sudhhirkumar PatelGreenville$12K
- Rica SantiagoMt Pleasant$10.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.